Primary Prevention Aspirin Use Decreased After Recommendation Change
Decrease in use seen among older adults, adults with low ASCVD risk, but also among those with higher ASCVD risk
Recent Decades Saw Rise in Sedative, Hypnotic, Anxiolytic Use Disorders
Findings seen among adolescent and young adult Medicaid enrollees
Guidance Developed for Diagnosis, Management of Eosinophilic Esophagitis
Suggested treatments for eosinophilic esophagitis include PPIs, topical steroids, empiric food elimination diet, biologics, endoscopic dilation
Considerable Uncertainty Exists Regarding Effects of Puberty Blockers
Two systematic reviews revealed very low-certainty evidence on outcomes for people with gender dysphoria
Trump Administration Puts Freeze on Release of Health Info From Government Agencies
Hold on reports, regulations, guidance, and announcements in place until at least the end of the month
Several Factors Play Role in Semaglutide Initiation for Obesity Without Diabetes
Female sex, antidepressant use, and type of health insurance significantly influence semaglutide initiation
Fewer Bleeding Events Seen With Abelacimab Than Rivaroxaban in A-Fib
Lower levels of free factor XI and fewer bleeding events seen in patients with atrial fibrillation at moderate-to-high risk for stroke
Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer
Improved survival seen with perioperative chemotherapy with FLOT versus preoperative chemoradiotherapy
FDA Warns Sanofi of Manufacturing Irregularities at Key Facility
Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicines
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Drug is the first and only approved monotherapy for refractory major depressive disorder
